Doctors are too quick to recommend expensive genetic counseling or testing for ovarian cancer, but at the same time often fail to refer women at high risk for the disease, government researchers said.
Popular Posts:
- Roche says skin cancer drug substantially shrinks
- Roche says skin cancer drug substantially shrinks
- Roche says skin cancer drug substantially shrinks
- Roche says skin cancer drug substantially shrinks
- 1 in 3 terminal cancer patients die in hospitals